(Prototype team page) |
Charlie Lee (Talk | contribs) |
||
Line 1: | Line 1: | ||
− | {{SSHS-Shenzhen}} | + | {{SSHS-Shenzhen/CSS}} |
− | + | ||
+ | <html lang="en"> | ||
+ | <head> | ||
+ | <meta charset="UTF-8"> | ||
+ | <title>Title</title> | ||
+ | <style> | ||
+ | h1{ | ||
+ | color: #fff; | ||
+ | padding:150px 50px 5px!important; font-size: 30px!important; text-align: center; | ||
+ | } | ||
+ | </style> | ||
+ | </head> | ||
+ | <body> | ||
− | <div class=" | + | <div class="banner1"> |
− | + | Results | |
− | + | ||
</div> | </div> | ||
+ | <h1> | ||
+ | The result | ||
+ | </h1> | ||
− | < | + | <p id="para"> |
+ | After finishing the vitro transcription, we put the adult P. striolata into glass bottles for doing the RNAi efficiency test. | ||
+ | </p> | ||
− | < | + | <center> |
− | < | + | <div class="ibox"> |
− | < | + | <center><img src="https://static.igem.org/mediawiki/2018/c/c7/T--SSHS-Shenzhen--demo1.jpg" width="100%"></center> |
− | < | + | <p id="note"> |
− | < | + | <b> |
− | </ | + | Fig.5-1 |
+ | </b> | ||
+ | Adult P. striolata and Brassica chinensis leaves were placed in the glass bottles. The solutions of siRNA/shRNA (10 ng/mL) were separately sprayed onto the leaves of Chinese cabbage every third day, each solution has two repeats. Around twenty adult beetles of P. striolata were tested per siRNA/shRNA sample. | ||
+ | </p > | ||
</div> | </div> | ||
+ | <center> | ||
+ | <div class="ibox"> | ||
+ | <center><img src=" | ||
+ | https://static.igem.org/mediawiki/2018/b/b7/T--SSHS-Shenzhen--results1.jpg | ||
+ | " width="100%"></center> | ||
+ | <p id="note"> | ||
+ | <b> | ||
+ | Table 5-1 | ||
+ | </b> | ||
+ | </p > | ||
+ | </div> | ||
+ | <center> | ||
+ | <div class="ibox"> | ||
+ | <center><img src=" | ||
+ | https://static.igem.org/mediawiki/2018/5/58/T--SSHS-Shenzhen--results2.jpg | ||
+ | " width="100%"></center> | ||
+ | <p id="note"> | ||
+ | <b> | ||
+ | Fig. 5-2 | ||
+ | </b> | ||
+ | The survival rate of Phyllotreta striolata at different days after siRNA/ shRNA treatment. | ||
+ | </p > | ||
+ | </div> | ||
− | <div class=" | + | <center> |
− | < | + | <div class="ibox"> |
− | + | <center><img src=" | |
− | + | https://static.igem.org/mediawiki/2018/d/db/T--SSHS-Shenzhen--results3-1.jpg | |
− | < | + | " width="100%"></center> |
− | < | + | <p id="note"> |
− | </ | + | <b> |
+ | Fig. 5-3 | ||
+ | </b> | ||
+ | Comparison of RNAi efficiencies between siRNA and shRNA | ||
+ | </p > | ||
</div> | </div> | ||
− | + | <center> | |
− | <div class=" | + | <div class="ibox"> |
− | + | <center><img src=" | |
− | + | https://static.igem.org/mediawiki/2018/5/5e/T--SSHS-Shenzhen--results3-2.jpg | |
− | + | " width="100%"></center> | |
− | + | <p id="note"> | |
− | + | <b> | |
− | + | Fig. 5-4 | |
− | <p> | + | </b> |
− | + | Comparison of RNAi efficiencies between different shRNAs | |
− | + | </p > | |
− | + | ||
− | + | ||
− | </ | + | |
− | + | ||
</div> | </div> | ||
− | + | <center> | |
− | + | <div class="ibox"> | |
− | < | + | <center><img src=" |
− | <div class=" | + | https://static.igem.org/mediawiki/2018/1/13/T--SSHS-Shenzhen--results4.jpg |
− | < | + | " width="100%"></center> |
− | + | <p id="note"> | |
− | + | <b> | |
− | + | Table 5-2 | |
− | + | </b> | |
− | < | + | The effect of nucleotide content of shRNA on RNAi efficiency |
− | </ | + | </p > |
</div> | </div> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
+ | <p id="para"> | ||
+ | By comparing the different degrees of decreasing survival rates, between siRNA and shRNA (Fig. 5-2), and between different shRNAs (Fig. 5-3), the RNAi efficiency had been showed. | ||
+ | Results show that all the samples tested, except ALR-siRNA-1, and AlR-shRNA-1, could trigger RNAi mechanism, which was demonstrated by the survival rate decrease after treatment (Table 5-1, Fig. 5-1). After 11 days of treatment, there was a slight decrease of survival rate in water treatment (100% to 94%), in ALR-siRNA-1 (100%-81%) and in ALR-shRNA-1(100%-100%). The survival rate decrease of other treatments are significant (between 34.5%-85%). The differences of RNAi efficiency between siRNA and its corresponding shRNA, which have the same target site, are not significant (Fig. 5-2). But the nucleotide content of siRNA/shRNA seems play a role in RNAi efficiency (Fig. 5-3). When the antisense strand of the siRNA/shRNA has a weak base pairing at 3′-end (presence of A/U), but a strong base pairing at 5′-end (presence of G/C), such as ALR-siRNA-1 and ALR-shRNA-1 (Table 5-3), the RNAi efficiency of this siRNA/shRNA is very low. This result may be caused by the failure of the antisense strand to be loaded into RNA-induced silencing complex (RISC), due to the lower free energy level at the 5’end comparing to that at the 3’end. | ||
+ | </p> | ||
+ | <br><br><br><br><br> | ||
+ | </body> | ||
</html> | </html> |
Revision as of 12:40, 14 October 2018
The result
After finishing the vitro transcription, we put the adult P. striolata into glass bottles for doing the RNAi efficiency test.
Fig.5-1 Adult P. striolata and Brassica chinensis leaves were placed in the glass bottles. The solutions of siRNA/shRNA (10 ng/mL) were separately sprayed onto the leaves of Chinese cabbage every third day, each solution has two repeats. Around twenty adult beetles of P. striolata were tested per siRNA/shRNA sample.
Table 5-1
Fig. 5-2 The survival rate of Phyllotreta striolata at different days after siRNA/ shRNA treatment.
Fig. 5-3 Comparison of RNAi efficiencies between siRNA and shRNA
Fig. 5-4 Comparison of RNAi efficiencies between different shRNAs
Table 5-2 The effect of nucleotide content of shRNA on RNAi efficiency
By comparing the different degrees of decreasing survival rates, between siRNA and shRNA (Fig. 5-2), and between different shRNAs (Fig. 5-3), the RNAi efficiency had been showed. Results show that all the samples tested, except ALR-siRNA-1, and AlR-shRNA-1, could trigger RNAi mechanism, which was demonstrated by the survival rate decrease after treatment (Table 5-1, Fig. 5-1). After 11 days of treatment, there was a slight decrease of survival rate in water treatment (100% to 94%), in ALR-siRNA-1 (100%-81%) and in ALR-shRNA-1(100%-100%). The survival rate decrease of other treatments are significant (between 34.5%-85%). The differences of RNAi efficiency between siRNA and its corresponding shRNA, which have the same target site, are not significant (Fig. 5-2). But the nucleotide content of siRNA/shRNA seems play a role in RNAi efficiency (Fig. 5-3). When the antisense strand of the siRNA/shRNA has a weak base pairing at 3′-end (presence of A/U), but a strong base pairing at 5′-end (presence of G/C), such as ALR-siRNA-1 and ALR-shRNA-1 (Table 5-3), the RNAi efficiency of this siRNA/shRNA is very low. This result may be caused by the failure of the antisense strand to be loaded into RNA-induced silencing complex (RISC), due to the lower free energy level at the 5’end comparing to that at the 3’end.